NHIF Benchmarking Program
Be part of NHIF’s benchmarking program to collect industry-wide, standardized data to establish a national reference point for performance and clinical metrics.
COVID-19 HOME INFUSION THERAPY PROGRAM (C-HIT)
Learn more about COVID-19 monoclonal antibodies and how to particpate in NHIA’s C-HIT program.ADVOCACY INITIATIVES
Compete in NHIA’s Advocacy Olympics & Podium Challenge.
Latest News
NHIA Submits Comments on Proposed 2022 Physician Fee Schedule
NHIA submitted comments to the Centers for Medicare and Medicaid Services (CMS) on a proposed rule that outlined CY 2022 payment policies under the Physician Fee Schedule and other changes to Medicare Part B payment polices.
September 13, 2021
NHIA To Publish Scholarly Journal for Infusion Therapies
This new scholarly journal will feature independent research and studies related to infused therapies, patient outcomes, medication safety, economic analyses, and case studies.
September 8, 2021
NHIA and 20+ Organizations Sign Joint Letter To Congress To Support Home Infusion Legislation
On September 8, a group of stakeholders, including home infusion providers, patient advocacy groups, professional societies, and industry suppliers, sent a letter to leaders in the House of Representatives and the Senate encouraging them to pass the Preserving Patient Access to Home Infusion Act (S 2652; H.R. 5067).
August 27, 2021
NHIA Comments On Medicare Home Health Proposed Rule
NHIA has submitted comments to CMS on the CY 2022 Home Health Rule which outlines proposed coverage and policy changes for home infusion and other post-acute services.
August 23, 2021
NHIA Applauds House Introduction of Bipartisan
Home Infusion Legislation
A companion bill to S.2652, The Preserving Patient Access to Home Infusion Act (H.R. 5067) — introduced in the House by Reps. Terri Sewell (D-AL), Debbie Dingell (D-MI), Fred Upton (R-MI), and Vern Buchannan (R-FL) — would ensure patients with serious viral and fungal infections, heart failure, immune diseases, cancer, and other conditions can receive the intravenous (IV) medications they need while at home.
August 5, 2021
Bipartisan Legislation Would Maintain Home Infusion Access Among Medicare Beneficiaries
The Preserving Patient Access to Home Infusion Act — introduced by Sen. Mark Warner (D-VA) and Sen. Tim Scott (R-SC) — would ensure patients with serious viral and fungal infections, heart failure, immune diseases, cancer, and other conditions can receive the intravenous (IV) medications they need while at home.
July 6, 2021
Open Comment Period of NHIF Proposed Standard Days Definitions
NHIF’s Outcomes Task Force has worked to define definitions for patient days, therapy days, and catheter days. Standard definitions assist in aligning data across the industry and assist in being able to further our current quality data initiatives. These proposed definitions are currently open for member comment until September 30, 2021.
June 16, 2021
Federal Court Dismisses NHIA’s Lawsuit Over Medicare Home Infusion Therapy Benefit
A U.S. district court dismissed NHIA’s case over the implementation of a Medicare home infusion therapy services benefit for a “lack of subject matter jurisdiction.”
